JBIO Insider Trading Activity and SEC Form 4 Filings
JBIO insider trading summary
No open-market insider purchases or sales of Jade Biosciences, Inc. (JBIO) have been reported on SEC Form 4 in the past 12 months.
Latest JBIO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 16, 2025 | Tom Frohlich | Chief Executive Officer | Buy | $44K (6,000 @ $7.40) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.